Aura Biosciences, Inc.
AURA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $363 | $294 | $408 |
| - Cash | $48 | $107 | $38 | $32 |
| + Debt | $15 | $18 | $18 | $19 |
| Enterprise Value | – | $274 | $274 | $395 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$0 | $0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$26 | -$27 | -$29 | -$26 |
| % Margin | – | – | – | – |
| Net Income | -$26 | -$27 | -$27 | -$26 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.4 | -0.47 | -0.55 | -0.52 |
| % Growth | 14.9% | 14.5% | -5.8% | – |
| Operating Cash Flow | -$20 | -$21 | -$23 | -$24 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$20 | -$21 | -$24 | -$24 |